UK researchers are to begin trials of inhaled coronavirus vaccines.
Delivering doses directly to the lungs might give a better immune response than conventional jabs, they say.
The Imperial College London team will use two frontrunners already in development – the Oxford one recently paused in trials and one from Imperial that entered human testing in June.
There are nearly 180 candidates being explored globally – but none has yet reached the end goal.
